Exchange: NASDAQ·Updated 02:26 AM EDT

IBRX News

News
all
press releases
ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Patrick Soon-Shiong, its Founder, Executive Chairman and Global Chief Scientific and Medical Officer, will participate virtually in a fireside chat at the Piper Sandler Virtual Oncology Symposium...
Business Wire
ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Patrick Soon-Shiong, its Founder, Executive Chairman and Global Chief Scientific and Medical Officer, will participate virtually in a fireside chat at the Piper Sandler Virtual Oncology Symposium...
Business Wire
More News
IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work
The initiative aligns with Soon-Shiong’s ‘Immunotherapy 2.0’ vision, combining immune treatments, diagnostics and monitoring to help prevent cancer recurrence.
Stocktwits
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.
Stocktwits
Nasdaq, S&P 500, Dow Futures Steady Ahead Of Fed Minutes This Week: TSLA, SPCX, CBRS, QCOM, PTC, IBRX Stocks In Focus
On Stocktwits, retail sentiment toward SPY and QQQ remained ‘bullish’ since last week.
Stocktwits
Dow, S&P 500, Nasdaq Futures Rise After Soft Jobs Report As Markets Await Fed Minutes: IBRX, SMCI, VST, SOFI Stocks In Focus
The September 2026 U.S. jobs report showed nonfarm payrolls increasing by a lower-than-expected 29,000 jobs, while the unemployment rate ticked up to 4.2%.
Stocktwits
IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick
Founder Patrick Soon-Shiong outlined an ‘Immunotherapy 2.0’ approach aimed at strengthening immune defenses and preventing cancer recurrence.
Stocktwits
Market Movers Go Wild and Lead Fresh Wave of Action
Today’s market action is being shaped by a striking mix of listings, including Alpha Modus Holdings (NASDAQ:AMOD), Stablecoin Development (NYSEAMERICAN:SDEV), Cycurion (NASDAQ:CYCU), ImmunityBio (NASDAQ:IBRX), XIAO-I Corporation (NASDAQ:AIXI), and NeOnc Technologies Holdings (NASDAQ:NTHI).
24-7 Market News
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.
Stocktwits
IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet
Vanguard’s six reporting entities collectively held 36.48 million shares after adding a net 2.43 million during Q2.
Stocktwits
Dow, S&P 500, Nasdaq Futures Rise Despite Soaring Treasury Yields As Markets Eye Jobs Report: MU, NKE, IBRX, CEG Stocks In Focus
The 10-year U.S. Treasury yield climbed to a 24-year high, soaring past 5.3% to levels last seen in 2002.
Stocktwits

Advertisement|Remove ads.